Tuesday, May 26, 2026
Today's Edition

EveryNews

Stories that matter, signal over noise

Society

Christina Applegate on living with multiple sclerosis: openness as a resource for patients and families

An actress spoke about how illness changed her daily life. Her openness is not only a personal story: it’s a reminder of the needs of patients and those who care for them.

Tetiana Suchkova-Ladik

By Tetiana Suchkova-Ladik

February 26, 2026 · 2 min read

Christina Applegate on living with multiple sclerosis: openness as a resource for patients and families

What happened

According to UNN, citing the Mirror, 54‑year‑old Christina Applegate, known for her roles in "Married... with Children" and "Dead to Me," continues to live with a diagnosis of multiple sclerosis (MS) that was made in 2021. In her memoir "You with Sad Eyes" she candidly describes how the illness changes her routine: severe fatigue, the need to spend more time in bed, and shifting roles within the family.

Key words — from Christina herself

“My life is not wrapped in a bow. People’s lives are sometimes truly awful. I try to be as honest and frank as possible.”

— Christina Applegate, actress

About family and care

Applegate emphasizes the role of her daughter Sadie (about 15 years old) and her husband (Martyn LeNoble) in everyday decisions. As the child herself says in excerpts from the memoir, even simple things — a trip or coming home — are planned with recovery and safety in mind.

“This is the only time we can be alone. I tell myself, ‘Just drive her there safely and come back home so she can lie down.’ And that’s what I do.”

— Sadie, Christina Applegate’s daughter

Why it matters to the reader

Applegate’s story matters not only as a public confession by a celebrity. First, openness reduces the stigma surrounding chronic neurological illnesses. Second, it raises questions about access to medical, psychological, and social support for patients and their loved ones — a topic that resonates in our country as well, especially amid war and the strain on the healthcare system.

Context: public figures and neurodegeneration

The press also mentions other public figures living with neurodegenerative diagnoses; for example, Bruce Willis’s family confirmed that he has frontotemporal dementia. Such cases draw attention to issues that often remain out of headlines: long‑term care, financial costs, and the psychosocial support of families.

Conclusion

Christina Applegate’s openness is more than a personal disclosure: it is a signal to society, the healthcare system, and policymakers. Will we be able to turn that signal into concrete steps — improving care, support, and access to services for patients with chronic illnesses? This question concerns each of us.

Related

Latest

Business

EU Against Google: Why the Latest Fine Could Change More Than Previous Ones

# European Regulators Target Google Again — This Time Over Digital Markets Act Violations. What's Behind the Accusations and Why It Matters Beyond the Corporation European regulators have renewed their scrutiny of Google, this time focusing on alleged violations of the Digital Markets Act. The charges underscore Brussels' increasingly aggressive stance on big tech monopolies and what officials say are anticompetitive practices. The accusations center on how Google leverages its dominance across multiple digital services — from search to advertising to mobile platforms — to disadvantage competitors. Regulators claim the company is using its market power in ways that stifle innovation and limit consumer choice. The case carries significance far beyond Google itself. It signals how the EU is attempting to enforce its landmark Digital Markets Act, legislation designed to curb the gatekeeping power of tech giants. A potential penalty could set precedent for how other large technology companies face similar scrutiny. For consumers and smaller tech firms, the outcome could reshape the digital landscape by creating more room for competition. For Google, fines and operational restrictions could fundamentally alter its business model in Europe, the world's most stringent regulatory market. The case also reflects a broader geopolitical divide, with the EU pursuing a regulatory approach that contrasts sharply with the lighter-touch oversight favored in the United States.

May 26, 2026